Reni J. Benjamin
Stock Analyst at Citizens
(2.93)
# 1,056
Out of 5,148 analysts
19
Total ratings
37.5%
Success rate
5.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Reni J. Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Upgrades: Market Outperform | $5 | $3.79 | +31.93% | 2 | Mar 3, 2026 | |
| IMMP Immutep | Initiates: Market Outperform | $10 | $2.67 | +274.53% | 2 | Feb 23, 2026 | |
| SMMT Summit Therapeutics | Reiterates: Market Outperform | $40 | $16.19 | +147.07% | 4 | Jan 30, 2026 | |
| BCAX Bicara Therapeutics | Initiates: Market Outperform | $31 | $17.59 | +76.24% | 1 | Jan 29, 2026 | |
| ZYME Zymeworks | Initiates: Market Outperform | $32 | $23.31 | +37.28% | 1 | Dec 3, 2025 | |
| ONC BeOne Medicines AG | Maintains: Market Outperform | $348 → $396 | $314.36 | +25.97% | 1 | Nov 7, 2025 | |
| SANA Sana Biotechnology | Maintains: Market Outperform | $5 → $8 | $4.15 | +92.77% | 1 | Oct 30, 2025 | |
| KURA Kura Oncology | Reiterates: Market Outperform | $24 | $8.68 | +176.50% | 2 | Oct 20, 2025 | |
| INBX Inhibrx Biosciences | Reiterates: Market Perform | n/a | $77.49 | - | 1 | Aug 22, 2025 | |
| HOWL Werewolf Therapeutics | Maintains: Market Outperform | $4 → $3 | $0.58 | +414.58% | 1 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $4 → $3 | $2.71 | +10.70% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.20 | - | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $22 → $10 | $5.73 | +74.52% | 1 | Aug 12, 2025 |
Iovance Biotherapeutics
Mar 3, 2026
Upgrades: Market Outperform
Price Target: $5
Current: $3.79
Upside: +31.93%
Immutep
Feb 23, 2026
Initiates: Market Outperform
Price Target: $10
Current: $2.67
Upside: +274.53%
Summit Therapeutics
Jan 30, 2026
Reiterates: Market Outperform
Price Target: $40
Current: $16.19
Upside: +147.07%
Bicara Therapeutics
Jan 29, 2026
Initiates: Market Outperform
Price Target: $31
Current: $17.59
Upside: +76.24%
Zymeworks
Dec 3, 2025
Initiates: Market Outperform
Price Target: $32
Current: $23.31
Upside: +37.28%
BeOne Medicines AG
Nov 7, 2025
Maintains: Market Outperform
Price Target: $348 → $396
Current: $314.36
Upside: +25.97%
Sana Biotechnology
Oct 30, 2025
Maintains: Market Outperform
Price Target: $5 → $8
Current: $4.15
Upside: +92.77%
Kura Oncology
Oct 20, 2025
Reiterates: Market Outperform
Price Target: $24
Current: $8.68
Upside: +176.50%
Inhibrx Biosciences
Aug 22, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $77.49
Upside: -
Werewolf Therapeutics
Aug 21, 2025
Maintains: Market Outperform
Price Target: $4 → $3
Current: $0.58
Upside: +414.58%
Aug 18, 2025
Maintains: Market Outperform
Price Target: $4 → $3
Current: $2.71
Upside: +10.70%
Aug 13, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $0.20
Upside: -
Aug 12, 2025
Maintains: Market Outperform
Price Target: $22 → $10
Current: $5.73
Upside: +74.52%